UPDATE 1-Physicians Formula gets rival buyout proposal

Thu Sep 6, 2012 4:38pm IST

Stocks

   

* Receives new offer at $4.90 per share

* Swander Pace had offered $4.25 per share

* New offer at a premium of 12 pct to Wednesday close

* Co says not yet determined bid as superior

Sept 6 (Reuters) - Cosmetics company Physicians Formula Holdings Inc, which in August agreed to go private with Swander Pace Capital, said it received a rival buyout offer of about $67.2 million from an unnamed party.

The new unsolicited, non-binding offer of $4.90 per share is at a 12 percent premium to Physicians Formula's Wednesday close of $4.37. Swander Pace had agreed to pay Physicians Formula shareholders $4.25 per share in cash.

Physicians Formula, which is evaluating the new proposal, said its board has not yet determined that the bid is superior to Swander Pace's proposal.

Founded in 1937, Physicians Formula sells high-priced cosmetics and skin care products at chains owned by Wal-Mart Stores Inc, Target Corp and Rite Aid Corp .

Shares of Physicians Formula, which has a market capitalization of about $60 million, have risen 19 percent since the Swander Pace deal was announced.

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.

  • Most Popular
  • Most Shared

Markets

REUTERS SHOWCASE

Segway in India

Segway in India

Segway’s India business pegs hope on tech-savvy Modi  Full Article 

Power Outage

Power Outage

Mumbai hit by power cuts  Full Article 

Commodities

Commodities

Gold imports, premiums to jump on festive demand - top refiner  Full Article 

Economic Worries

Economic Worries

Pakistan's promises to IMF in doubt as protests sap economy   Full Article 

Islamic Finance

Islamic Finance

Basel III deposit challenge looms over Islamic banks   Full Article 

Antitrust Probes

Antitrust Probes

U.S. business lobby says concerned China antitrust probes unfair.  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage